(See the editorial commentary by Dartois, on pages 1827–9 .) Background. It is believed
that nonadherence is the proximate cause of multidrug-resistant tuberculosis (MDR-tuberculosis…

Background. Using hollow-fiber tuberculosis studies, we recently demonstrated that
nonadherence is not a significant factor for ADR and that therapy failure only occurs after a large …

We hypothesize that low-level efflux pump expression is the first step in the development of
high-level drug resistance in mycobacteria. We performed 28-day azithromycin dose-effect …

Background. Ethambutol is used for the treatment of tuberculosis in cases where there is
isoniazid resistance. We examined the emergence of drug resistance to ethambutol …

Rationale: Acquired resistance is an important driver of multidrug-resistant tuberculosis (TB),
even with good treatment adherence. However, exactly what initiates the resistance and …

Background. The role of drug concentrations in clinical outcomes in children with tuberculosis
is unclear. Target concentrations for dose optimization are unknown. Methods. Plasma …

In pharmacokinetic/pharmacodynamic models of pulmonary Mycobacterium abscessus
complex, the recommended macrolide-containing combination therapy has poor kill rates. …

Tuberculosis (TB) is the leading cause of death from a single infectious agent, requiring at
least 6 months of multidrug treatment to achieve cure 1 . However, the lack of reliable data on …

Linezolid has an excellent sterilizing effect in tuberculosis patients but high adverse event
rates. The dose that would maximize efficacy and minimize toxicity is unknown. We performed …

Background Levofloxacin is used for the treatment of multidrug-resistant tuberculosis;
however the optimal dose is unknown. Methods We used the hollow fiber system model of …